The in vitro activity of LY 264826, a new glycopeptide antibiotic, was compared with that of vancomycin against 100 strains each of methicillin-resistant Staphylococcus aureus and Clostridium difficile. LY 264826 was more active, by weight, than vancomycin against the isolates tested. The human serum protein binding of LY 264826 was 15.3% (range, 9.8 to 21.8%).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC171979 | PMC |
| http://dx.doi.org/10.1128/AAC.34.10.2007 | DOI Listing |
Publication Analysis
Top Keywords
vitro activity
8
activity 264826
8
compared vancomycin
8
vancomycin 100
8
methicillin-resistant staphylococcus
8
staphylococcus aureus
8
aureus clostridium
8
clostridium difficile
8
0
4
264826 compared
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!